Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Dr. Miller said he was optimistic that the clinical trial results would support an F.D.A. approval, but if or when that might happen is unclear, especially given recent changes at the agency.